Skip to main content

Youth

What's new

DreaMed’s artificial intelligence platform, Advisor Pro, which can deliver insulin dosing recommendations is now FDA approved for people with diabetes on multiple daily injections therapy. Because doing the math and analysis to make manual dosing adjustments can be both time consuming and distracting, this platform can help simplify the process and get people access to quality care, remotely. Continue Reading »

Whether your child has type 1 or type 2 diabetes, figuring out nutrition for school and childcare is a big part of managing glucose numbers – as well as nourishing a growing body. Continue Reading »

The number of youths being diagnosed with type 2 diabetes each year is on the rise. Learn about the early signs of type 2 diabetes in children and adolescents, the latest approved treatments, methods of prevention, and much more. Continue Reading »

diaTribe’s Director of Institutional Giving, Julie Heverly, shares the story of how misinformation and doubt challenged her to rethink pregnancy with type 1 diabetes, and how she was empowered to start a family. Continue Reading »

The FDA recently approved BYDUREON BCise (an extended-release version of the GLP-1 drug, exenatide) for teens with type 2 diabetes. Recently published data shows disturbingly high rates and serious diabetes complications in people who develop type 2 diabetes at a young age suggesting the need for aggressive early treatment and more treatment options.  Continue Reading »

Adolescence can be a confusing time, and this is doubly true for teenagers with type 1 diabetes. At a stage when everyone is starting to figure out who they are, the teenager with type 1 must also decide how much they want diabetes to be a part of their identity. Katie Bacon, the mother of a teenager with type 1, spoke with a range of experts and peers who shared their expertise and experiences on this subject. Continue Reading »

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »

David Kendall and Danilo Verge of Zealand Pharma spoke with diaTribe about Zegalogue (dasiglucagon), a new emergency glucagon injection used to treat severe hypoglycemia in people with diabetes over the age of six. Read their insights on this life-saving treatment. Continue Reading »

Pages